|
|
||||||||




* NRS Centre National de la Recherche Scientifique, Molecular Immunology and Embryology, Orléans, France;
Laboratoire des Mécanismes Moléculaires de la Pathogénie Microbienne, Institut National de la Santé et de la Recherche Médicale Unité 447, Institut Pasteur de Lille/IBL, Lille, France;
Unité de Glycobiologie Structurale et Fonctionnelle, Unité Mixte de Recherche 8576 du Centre National de la Recherche Scientifique, IFR 118, Université des Sciences et Technologies de Lille, Villeneuve dAscq, France; and
Département des Mécanismes Moléculaires des Infections Mycobactériennes, Institut de Pharmacologie et de Biologie Structurale du Centre National de la Recherche Scientifique, UMR 5089, Toulouse, France
Lipoarabinomannans (LAM) and lipomannans (LM) are integral parts of the mycobacterial cell wall recognized by cells involved in the innate immune response and have been found to modulate the cytokine response. Typically, mannosylated LAM from pathogenic mycobacteria have been reported to be anti-inflammatory, whereas phosphoinositol-substituted LAM from nonpathogenic species are proinflammatory molecules. In this study, we show that LM from several mycobacterial species, including Mycobacterium chelonae, Mycobacterium kansasii, and Mycobacterium bovis bacillus Calmette-Guérin, display a dual function by stimulating or inhibiting proinflammatory cytokine synthesis through different pathways in murine primary macrophages. LM, but none of the corresponding LAM, induce macrophage activation characterized by cell surface expression of CD40 and CD86 and by TNF and NO secretion. This activation is dependent on the presence of Toll-like receptor (TLR) 2 and mediated through the adaptor protein myeloid differentiation factor 88 (MyD88), but independent of either TLR4 or TLR6 recognition. Surprisingly, LM exerted also a potent inhibitory effect on TNF, IL-12p40, and NO production by LPS-activated macrophages. This TLR2-, TLR6-, and MyD88-independent inhibitory effect is also mediated by LAM from M. bovis bacillus Calmette-Guérin but not by LAM derived from M. chelonae and M. kansasii. This study provides evidence that mycobacterial LM bear structural motifs susceptible to interact with different pattern recognition receptors with pro- or anti-inflammatory effects. Thus, the ultimate response of the host may therefore depend on the prevailing LM or LAM in the mycobacterial envelope and the local host cell receptor availability.
This article has been cited by other articles:
![]() |
Y.-C. Chang, W.-C. Kao, W.-Y. Wang, W.-Y. Wang, R.-B. Yang, and K. Peck Identification and characterization of oligonucleotides that inhibit Toll-like receptor 2-associated immune responses FASEB J, September 1, 2009; 23(9): 3078 - 3088. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Doz, S. Rose, N. Court, S. Front, V. Vasseur, S. Charron, M. Gilleron, G. Puzo, I. Fremaux, Y. Delneste, et al. Mycobacterial Phosphatidylinositol Mannosides Negatively Regulate Host Toll-like Receptor 4, MyD88-dependent Proinflammatory Cytokines, and TRIF-dependent Co-stimulatory Molecule Expression J. Biol. Chem., August 28, 2009; 284(35): 23187 - 23196. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Rhoades, A. S. Archambault, R. Greendyke, F.-F. Hsu, C. Streeter, and T. F. Byrd Mycobacterium abscessus Glycopeptidolipids Mask Underlying Cell Wall Phosphatidyl-myo-Inositol Mannosides Blocking Induction of Human Macrophage TNF-{alpha} by Preventing Interaction with TLR2 J. Immunol., August 1, 2009; 183(3): 1997 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mendez-Samperio, E. Miranda, and A. Trejo Expression and Secretion of Cathelicidin LL-37 in Human Epithelial Cells after Infection by Mycobacterium bovis Bacillus Calmette-Guerin Clin. Vaccine Immunol., September 1, 2008; 15(9): 1450 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, A. Hasegawa, H. Hosokawa, M. Yamashita, S. Motohashi, T. Naka, Y. Okamoto, Y. Fujita, Y. Ishii, M. Taniguchi, et al. Human Th1 differentiation induced by lipoarabinomannan/lipomannan from Mycobacterium bovis BCG Tokyo-172 Int. Immunol., July 1, 2008; 20(7): 849 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nigou, T. Vasselon, A. Ray, P. Constant, M. Gilleron, G. S. Besra, I. Sutcliffe, G. Tiraby, and G. Puzo Mannan Chain Length Controls Lipoglycans Signaling via and Binding to TLR2 J. Immunol., May 15, 2008; 180(10): 6696 - 6702. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Doz, S. Rose, J. Nigou, M. Gilleron, G. Puzo, F. Erard, B. Ryffel, and V. F. J. Quesniaux Acylation Determines the Toll-like receptor (TLR)-dependent Positive Versus TLR2-, Mannose Receptor-, and SIGNR1-independent Negative Regulation of Pro-inflammatory Cytokines by Mycobacterial Lipomannan J. Biol. Chem., September 7, 2007; 282(36): 26014 - 26025. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hajishengallis, M.-A. K. Shakhatreh, M. Wang, and S. Liang Complement Receptor 3 Blockade Promotes IL-12-Mediated Clearance of Porphyromonas gingivalis and Negates Its Virulence In Vivo J. Immunol., August 15, 2007; 179(4): 2359 - 2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Fremond, D. Togbe, E. Doz, S. Rose, V. Vasseur, I. Maillet, M. Jacobs, B. Ryffel, and V. F. J. Quesniaux IL-1 Receptor-Mediated Signal Is an Essential Component of MyD88-Dependent Innate Response to Mycobacterium tuberculosis Infection J. Immunol., July 15, 2007; 179(2): 1178 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Young, L. Slobbe, R. Wilson, B. M. Buddle, G. W. de Lisle, and G. S. Buchan Environmental Strains of Mycobacterium avium Interfere with Immune Responses Associated with Mycobacterium bovis BCG Vaccination Infect. Immun., June 1, 2007; 75(6): 2833 - 2840. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liang, M. Wang, K. Triantafilou, M. Triantafilou, H. F. Nawar, M. W. Russell, T. D. Connell, and G. Hajishengallis The A Subunit of Type IIb Enterotoxin (LT-IIb) Suppresses the Proinflammatory Potential of the B Subunit and Its Ability to Recruit and Interact with TLR2 J. Immunol., April 15, 2007; 178(8): 4811 - 4819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-P. Puissegur, G. Lay, M. Gilleron, L. Botella, J. Nigou, H. Marrakchi, B. Mari, J.-L. Duteyrat, Y. Guerardel, L. Kremer, et al. Mycobacterial Lipomannan Induces Granuloma Macrophage Fusion via a TLR2-Dependent, ADAM9- and beta1 Integrin-Mediated Pathway J. Immunol., March 1, 2007; 178(5): 3161 - 3169. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. van Duin, S. Mohanty, V. Thomas, S. Ginter, R. R. Montgomery, E. Fikrig, H. G. Allore, R. Medzhitov, and A. C. Shaw Age-Associated Defect in Human TLR-1/2 Function J. Immunol., January 15, 2007; 178(2): 970 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Murray, M. R. Siddiqui, M. Mendillo, J. Krahenbuhl, and G. Kaplan Mycobacterium leprae Inhibits Dendritic Cell Activation and Maturation J. Immunol., January 1, 2007; 178(1): 338 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kurtz, K. P. McKinnon, M. S. Runge, J. P.-Y. Ting, and M. Braunstein The SecA2 Secretion Factor of Mycobacterium tuberculosis Promotes Growth in Macrophages and Inhibits the Host Immune Response Infect. Immun., December 1, 2006; 74(12): 6855 - 6864. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sharma, A. Saha, S. Bhattacharjee, S. Majumdar, and S. K. Das Gupta Specific and Randomly Derived Immunoactive Peptide Mimotopes of Mycobacterial Antigens Clin. Vaccine Immunol., October 1, 2006; 13(10): 1143 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kaur, S. Berg, P. Dinadayala, B. Gicquel, D. Chatterjee, M. R. McNeil, V. D. Vissa, D. C. Crick, M. Jackson, and P. J. Brennan Biosynthesis of mycobacterial lipoarabinomannan: Role of a branching mannosyltransferase PNAS, September 12, 2006; 103(37): 13664 - 13669. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dinadayala, D. Kaur, S. Berg, A. G. Amin, V. D. Vissa, D. Chatterjee, P. J. Brennan, and D. C. Crick Genetic Basis for the Synthesis of the Immunomodulatory Mannose Caps of Lipoarabinomannan in Mycobacterium tuberculosis J. Biol. Chem., July 21, 2006; 281(29): 20027 - 20035. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Pecora, A. J. Gehring, D. H. Canaday, W. H. Boom, and C. V. Harding Mycobacterium tuberculosis LprA Is a Lipoprotein Agonist of TLR2 That Regulates Innate Immunity and APC Function J. Immunol., July 1, 2006; 177(1): 422 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-B. Jung, C.-S. Yang, J.-S. Lee, A-R. Shin, S.-S. Jung, J. W. Son, C. V. Harding, H.-J. Kim, J.-K. Park, T.-H. Paik, et al. The Mycobacterial 38-Kilodalton Glycolipoprotein Antigen Activates the Mitogen-Activated Protein Kinase Pathway and Release of Proinflammatory Cytokines through Toll-Like Receptors 2 and 4 in Human Monocytes. Infect. Immun., May 1, 2006; 74(5): 2686 - 2696. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Banaiee, E. Z. Kincaid, U. Buchwald, W. R. Jacobs Jr., and J. D. Ernst Potent Inhibition of Macrophage Responses to IFN-{gamma} by Live Virulent Mycobacterium tuberculosis Is Independent of Mature Mycobacterial Lipoproteins but Dependent on TLR2. J. Immunol., March 1, 2006; 176(5): 3019 - 3027. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Pathak, S. Basu, A. Bhattacharyya, S. Pathak, M. Kundu, and J. Basu Mycobacterium tuberculosis Lipoarabinomannan-mediated IRAK-M Induction Negatively Regulates Toll-like Receptor-dependent Interleukin-12 p40 Production in Macrophages J. Biol. Chem., December 30, 2005; 280(52): 42794 - 42800. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Elass, L. Aubry, M. Masson, A. Denys, Y. Guerardel, E. Maes, D. Legrand, J. Mazurier, and L. Kremer Mycobacterial Lipomannan Induces Matrix Metalloproteinase-9 Expression in Human Macrophagic Cells through a Toll-Like Receptor 1 (TLR1)/TLR2- and CD14-Dependent Mechanism Infect. Immun., October 1, 2005; 73(10): 7064 - 7068. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Drennan, B. Stijlemans, J. Van Den Abbeele, V. J. Quesniaux, M. Barkhuizen, F. Brombacher, P. De Baetselier, B. Ryffel, and S. Magez The Induction of a Type 1 Immune Response following a Trypanosoma brucei Infection Is MyD88 Dependent J. Immunol., August 15, 2005; 175(4): 2501 - 2509. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. C. Gibson, M. Gilleron, P. Constant, B. Sichi, G. Puzo, G. S. Besra, and J. Nigou A Lipomannan Variant with Strong TLR-2-dependent Pro-inflammatory Activity in Saccharothrix aerocolonigenes J. Biol. Chem., August 5, 2005; 280(31): 28347 - 28356. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fernandez, S. Alonso, I. Valera, A. G. Vigo, M. Renedo, L. Barbolla, and M. S. Crespo Mannose-Containing Molecular Patterns Are Strong Inducers of Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Macrophages J. Immunol., June 15, 2005; 174(12): 8154 - 8162. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gilleron, N. J. Garton, J. Nigou, T. Brando, G. Puzo, and I. C. Sutcliffe Characterization of a Truncated Lipoarabinomannan from the Actinomycete Turicella otitidis J. Bacteriol., February 1, 2005; 187(3): 854 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nicolle, C. Fremond, X. Pichon, A. Bouchot, I. Maillet, B. Ryffel, and V. J. F. Quesniaux Long-Term Control of Mycobacterium bovis BCG Infection in the Absence of Toll-Like Receptors (TLRs): Investigation of TLR2-, TLR6-, or TLR2-TLR4-Deficient Mice Infect. Immun., December 1, 2004; 72(12): 6994 - 7004. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |